A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge

NARecruitingINTERVENTIONAL

Enrollment

560

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Brain DiseaseVertebral Artery Stenosis

Interventions

DRUG

Ticagrelor

To compare the safety and efficacy of different DAPT duration combined with ticagrelor monotherapy.

Trial Locations (1)

RECRUITING

the Fourth Affiliated Hospital of China Medical University, Shenyang

All Listed Sponsors

lead

The Fourth Affiliated Hospital of China Medical University

OTHER